source
- Trump administration abandons Biden Ebola response plan, opting for new strategyThe Biden administration completed a multi-hundred-page set of guidelines in early 2025 outlining how federal agencies should handle future disease threats, including protocols for Ebola outbreaks…
- Bristol Myers reports Phase 3 data showing mezigdomide extends survival in relapsed multiple myelomaBristol Myers Squibb presented Phase 3 results for its experimental multiple myeloma drug mezigdomide at the American Society of Clinical Oncology meeting. The study evaluated mezigdomide combined…